Related Experiment Video
Updated: Oct 2, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Two Cases of Acute Direct Oral Anticoagulant Overdose Without Adverse Effect
Catherine J Ha1, Elie Harmouche2, Mary Ann Howland3,4
1Columbia University Vagelos College of Physicians and Surgeons.
Two pediatric patients overdosed on direct oral anticoagulants (DOACs) but recovered without bleeding or needing reversal agents. A standard heparin anti-Factor Xa assay showed correlation with rivaroxaban levels, suggesting its potential utility.
Area of Science:
- Pediatric Pharmacology
- Clinical Toxicology
- Pharmacokinetics
Background:
- Direct oral anticoagulants (DOACs) are increasingly used for anticoagulation.
- Accidental overdoses in children present unique management challenges.
- Assessing DOAC levels in overdose is crucial but often difficult due to assay limitations.
Purpose of the Study:
- To describe the clinical management of pediatric patients with acute DOAC overdose.
- To evaluate the utility of a routine heparin anti-Factor Xa assay in a pediatric DOAC overdose case.
Main Methods:
- Case report of two pediatric patients with acute DOAC overdose.
- Conservative management including supportive care.
- Laboratory analysis using a routine hybrid heparin anti-Factor Xa assay.
Main Results:
- Both patients were managed conservatively without major or minor bleeding.
- Neither patient required reversal agents or blood products.
- A linear correlation was observed between serum rivaroxaban concentration and the heparin anti-Factor Xa assay up to 940 ng/mL.
Conclusions:
- Conservative management can be effective for pediatric DOAC overdose.
- Routine coagulation studies are insufficient for monitoring DOAC therapy or overdose.
- A standard heparin anti-Factor Xa assay may offer a practical alternative for estimating DOAC levels when specific assays are unavailable.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Venous Thrombosis III: Interprofessional Care
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...

